Cargando…

Implications of LDH in patients with coronavirus disease 2019 pneumonia

OBJECTIVE: The objective of this study was to explore the value of serum lactic dehydrogenase (LDH) in the early diagnosis and prognostic evaluation of pneumonia associated with the novel coronavirus infection. METHODS: A total of 101 patients with coronavirus disease 2019 (COVID-19) pneumonia were...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Tong, Wang, Xingguang, Lu, Zhiming, Tong, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642759/
https://www.ncbi.nlm.nih.gov/pubmed/37965268
http://dx.doi.org/10.3389/fcimb.2023.1180187
_version_ 1785147017608036352
author Mu, Tong
Wang, Xingguang
Lu, Zhiming
Tong, Jia
author_facet Mu, Tong
Wang, Xingguang
Lu, Zhiming
Tong, Jia
author_sort Mu, Tong
collection PubMed
description OBJECTIVE: The objective of this study was to explore the value of serum lactic dehydrogenase (LDH) in the early diagnosis and prognostic evaluation of pneumonia associated with the novel coronavirus infection. METHODS: A total of 101 patients with coronavirus disease 2019 (COVID-19) pneumonia were included in the study. According to the severity of the initial chest computed tomography (CT), the patients were divided into the ordinary pneumonia group and the severe pneumonia group and then divided into the remission group and the nonremission group according to the changes of the chest CT after medication treatment. The differences in general characteristics, underlying diseases, clinical symptoms, laboratory findings, and imaging examination outcomes between groups were observed retrospectively. To analyze the diagnostic performance of LDH, receiver operating characteristic (ROC) curves were constructed and the area under the curve (AUC) was calculated. RESULTS: Compared with ordinary pneumonia patients, patients in the severe group presented with significantly higher LDH, neutrophil count, high-sensitivity troponin T (HS-TnT), C-reactive protein (CRP), human serum amyloid A (SAA), N-terminal pro-brain natriuretic peptide (NTproBNP), and D-dimer. Compared with remission patients, non-remission patients presented with significantly higher LDH, neutrophil count, HS-TnT, CRP, SAA, procalcitonin (PCT), creatine kinase–MB mass (CKMB_M), NTproBNP, and D-dimer. In multivariate logistic regression analysis, we found that LDH [odds ratio (OR), 1.015; 95% confidence interval (CI), 1.006–1024; p = 0.001] and neutrophil count (OR, 1.352; 95% CI, 1.008–1.811; p = 0.044) were independently associated with exacerbation in COVID-19 patients. For ROC analysis, the AUC was 0.833 (95% CI, 0.729–0.936; p < 0.001) when we use the LDH value of 256.69 U/L to discriminate the ordinary pneumonia and severe pneumonia patients. The AUC was 0.759 (95% CI, 0.603–0.914; p = 0.008) and the sensitivity is 92.3% when we combined the LDH (cutoff value 258.46 U/L) and the neutrophil count (cutoff value 6.76 × 10(9)/L) to discriminate remission and non-remission patients. CONCLUSION: The level of LDH is associated with the severity of COVID-19 pneumonia and can be used as important indicators to evaluate the prognosis of patients.
format Online
Article
Text
id pubmed-10642759
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106427592023-11-14 Implications of LDH in patients with coronavirus disease 2019 pneumonia Mu, Tong Wang, Xingguang Lu, Zhiming Tong, Jia Front Cell Infect Microbiol Cellular and Infection Microbiology OBJECTIVE: The objective of this study was to explore the value of serum lactic dehydrogenase (LDH) in the early diagnosis and prognostic evaluation of pneumonia associated with the novel coronavirus infection. METHODS: A total of 101 patients with coronavirus disease 2019 (COVID-19) pneumonia were included in the study. According to the severity of the initial chest computed tomography (CT), the patients were divided into the ordinary pneumonia group and the severe pneumonia group and then divided into the remission group and the nonremission group according to the changes of the chest CT after medication treatment. The differences in general characteristics, underlying diseases, clinical symptoms, laboratory findings, and imaging examination outcomes between groups were observed retrospectively. To analyze the diagnostic performance of LDH, receiver operating characteristic (ROC) curves were constructed and the area under the curve (AUC) was calculated. RESULTS: Compared with ordinary pneumonia patients, patients in the severe group presented with significantly higher LDH, neutrophil count, high-sensitivity troponin T (HS-TnT), C-reactive protein (CRP), human serum amyloid A (SAA), N-terminal pro-brain natriuretic peptide (NTproBNP), and D-dimer. Compared with remission patients, non-remission patients presented with significantly higher LDH, neutrophil count, HS-TnT, CRP, SAA, procalcitonin (PCT), creatine kinase–MB mass (CKMB_M), NTproBNP, and D-dimer. In multivariate logistic regression analysis, we found that LDH [odds ratio (OR), 1.015; 95% confidence interval (CI), 1.006–1024; p = 0.001] and neutrophil count (OR, 1.352; 95% CI, 1.008–1.811; p = 0.044) were independently associated with exacerbation in COVID-19 patients. For ROC analysis, the AUC was 0.833 (95% CI, 0.729–0.936; p < 0.001) when we use the LDH value of 256.69 U/L to discriminate the ordinary pneumonia and severe pneumonia patients. The AUC was 0.759 (95% CI, 0.603–0.914; p = 0.008) and the sensitivity is 92.3% when we combined the LDH (cutoff value 258.46 U/L) and the neutrophil count (cutoff value 6.76 × 10(9)/L) to discriminate remission and non-remission patients. CONCLUSION: The level of LDH is associated with the severity of COVID-19 pneumonia and can be used as important indicators to evaluate the prognosis of patients. Frontiers Media S.A. 2023-10-30 /pmc/articles/PMC10642759/ /pubmed/37965268 http://dx.doi.org/10.3389/fcimb.2023.1180187 Text en Copyright © 2023 Mu, Wang, Lu and Tong https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Mu, Tong
Wang, Xingguang
Lu, Zhiming
Tong, Jia
Implications of LDH in patients with coronavirus disease 2019 pneumonia
title Implications of LDH in patients with coronavirus disease 2019 pneumonia
title_full Implications of LDH in patients with coronavirus disease 2019 pneumonia
title_fullStr Implications of LDH in patients with coronavirus disease 2019 pneumonia
title_full_unstemmed Implications of LDH in patients with coronavirus disease 2019 pneumonia
title_short Implications of LDH in patients with coronavirus disease 2019 pneumonia
title_sort implications of ldh in patients with coronavirus disease 2019 pneumonia
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642759/
https://www.ncbi.nlm.nih.gov/pubmed/37965268
http://dx.doi.org/10.3389/fcimb.2023.1180187
work_keys_str_mv AT mutong implicationsofldhinpatientswithcoronavirusdisease2019pneumonia
AT wangxingguang implicationsofldhinpatientswithcoronavirusdisease2019pneumonia
AT luzhiming implicationsofldhinpatientswithcoronavirusdisease2019pneumonia
AT tongjia implicationsofldhinpatientswithcoronavirusdisease2019pneumonia